This study aimed to identify metabolic dysregulation in iPSC-derived human dopamine neurons carrying a mutation in the MAPT gene which may be driving pathogenesis in PD, with a focus on oxidised phospholipids. This evidence concerns the gene MAPT and Parkinson disease.